Navigation Links
Summary Letter to Hadasit Bio-Holdings Ltd. Shareholders
Date:10/26/2011

ges - scientific efficacy in animal models that show great promise.  In addition, our public listing has provided financial strength and had the cash and cash equivalence of about $5.4 million as of June 30, 2011.

Recent Developments:

In response to investor interest, Hadasit Bio-Holdings Ltd. issued American Depositary receipts (ADR's), in partnership with The Bank of New York to expose US investors to the company. After a June launch, market makers joined on making it possible to trade stock in the United States on the OTC Bulletin Board Exchange under the symbol "HADSY".  This allowed foreign investors who are familiar with the Hadassah Hospital, its exceptional level of medical care and innovation, as well as the wider, general investment community who views Israel as an innovative force in the Biomed and Life Sciences field, to easily access Hadasit Bio-Holdings Ltd. stock in the USA.

Our unique holding company model extending a private hospital in to the public market has attracted global interest.  Delegations from all over the world including China, Sweden, Russia and the USA have studied our business to explore the model and potential partnership possibilities.

Investment options in new and fascinating companies are constantly being examined as our current portfolio matures. In order to manage risk and to utilize the relative advantage Hadasit Bio has as a holding company with a hospital in its back yard, we have developed an innovative business model for these investments. The model is based on a relatively small initial investment for the purpose of financing a feasibility trial with one of Hadassah's specialists, while receiving the option of investing significantly more and under better conditions after the success of the trial.

Following is a concise study of the prominent portfolio companies of Hadasit:

Thrombotech Ltd.

Thrombotech is involved in the development of
'/>"/>

SOURCE Hadasit Bio-Holdings Ltd.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6

Related biology technology :

1. Huifeng Bio-Pharmaceutical (HFGB) Enters into Letter of Intent with Xian Qinba Xintong Medical Ltd.
2. CTI Receives NASDAQ Letter
3. Synvista Therapeutics Posts Letter to Stockholders on Web Site
4. Oncothyreon announces receipt of NASDAQ letter regarding compliance with NASDAQ Global Market listing standards
5. Letter to Shareholders from the CEO and Chairman of the Board of Yongye Biotechnology, Inc.
6. Advanced Life Sciences Announces Receipt of Nasdaq Staff Letter
7. Vical and AnGes MG Sign Letter of Intent for Pandemic Influenza Program
8. Cell Therapeutics to Request a Hearing With NASDAQ Following Receipt of Staff Determination Letter
9. Spherix Receives Nasdaq Letter Extending Minimum Bid Price Compliance Period
10. Caraco Pharmaceutical Laboratories, Ltd. Receives FDA Warning Letter
11. deCODE Requests Hearing With Nasdaq Following Receipt of Staff Determination Letter
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... 2013 The New Jersey chapter of ... Data Processing Associates (BDPA), is hosting its 10th annual ... This all-day event will encourage students and their parents ... and outs from many of the industries’ finest teachers. ... New Jersey Institute of Technology, the event will include ...
(Date:5/23/2013)... Korea , May 23, 2013 ... SillaJen, Inc., a private biotherapeutics and contract research ... biological products for cancer, announced today a publication ... patients treated with the oncolytic and immunotherapeutic vaccinia ... This research was published in the May 15 ...
(Date:5/23/2013)... Bed bugs compromised Penn State. ... confirmed it. Meanwhile, My Cleaning Products offered complimentary samples of ... the pests without using harmful chemical elements. , Based ... the affected building was actually a dormitory , My ... made on May 13 and bed bug presence was confirmed ...
(Date:5/22/2013)... 22, 2013 Oven Industries announces the ... integrated potentiometers or via a PC through the TTL ... and one half inches square can deliver up to ... switched, low noise solid state relay. Operator safety is ... the communication port and sensor input. Specifications: Input ...
Breaking Biology Technology:Black Data Processing Associates (BDPA) New Jersey Hosts 10th Annual Families in Technology Day June 8, 2013 2Pusan National University Announces Science Translational Medicine Publication Highlighting Landmark Demonstration of Functional Anti-Cancer Antibody Induction in Patients Following JX-594 Treatment 2Pusan National University Announces Science Translational Medicine Publication Highlighting Landmark Demonstration of Functional Anti-Cancer Antibody Induction in Patients Following JX-594 Treatment 3Penn State Dorm Infested with Bed Bugs, My Cleaning Products Offers Complimentary Sample of Bed Bug Spray to Help Bed Bug Victims 2New AC Temperature Controller Announced by Oven Industries 2
... Novagali Pharma, a French,pharmaceutical ophthalmic company, announces ... (IND) to conduct a Phase III clinical,trial ... glaucoma has been,granted by the U.S. Food ... ocular proprietary BAK-free formulation of latanoprost which,furthermore ...
... Milestone Payment from GlaxoSmithKlineMOUNTAIN VIEW, Calif., May 5 ... identified an orally bioavailable small molecule antagonist of ... clinical development. The acceptance of the molecule ... milestone payment from the alliance with GlaxoSmithKline (NYSE: ...
... May 5 Amylin Pharmaceuticals, Inc., (Nasdaq: ... LLY ) and Alkermes, Inc. (Nasdaq: ALKS ) ... once weekly has been submitted to the U.S. Food and ... release medication for type 2 diabetes that is injected subcutaneously ...
Cached Biology Technology:Novagali Pharma Announces FDA Clearance of IND for Phase III of Catioprost(R), its Cationic Emulsion of Latanoprost in Patients With Glaucoma 2ChemoCentryx Identifies Novel Small Molecule C5aR Antagonist 2ChemoCentryx Identifies Novel Small Molecule C5aR Antagonist 3ChemoCentryx Identifies Novel Small Molecule C5aR Antagonist 4Exenatide Once Weekly New Drug Application Submitted to FDA for Type 2 Diabetes 2Exenatide Once Weekly New Drug Application Submitted to FDA for Type 2 Diabetes 3Exenatide Once Weekly New Drug Application Submitted to FDA for Type 2 Diabetes 4Exenatide Once Weekly New Drug Application Submitted to FDA for Type 2 Diabetes 5Exenatide Once Weekly New Drug Application Submitted to FDA for Type 2 Diabetes 6Exenatide Once Weekly New Drug Application Submitted to FDA for Type 2 Diabetes 7
(Date:5/22/2013)... have developed a novel technique that can detect molecular ... that is one of the most important, though time-consuming, ... a paper in Nature , post-doctoral researcher David ... Schnell of the Center for Free-Electron Laser Science (CFEL) ... finely-tuned microwave fields to identify molecular variants apart, and ...
(Date:5/22/2013)... 2013)The omega 3 fatty acids in fish oil have ... so that the American Heart Association currently recommends eating ... fatty varieties rich in omega 3s. However, the mechanism ... a new study, scientists led by Jason R. Carter ... by providing evidence that fish oil might specifically counteract ...
(Date:5/22/2013)... human health effects from disposal of millions of ... to recommend stronger government policies to encourage recovery, ... That,s the conclusion of a new paper in ... . , Oladele A. Ogunseitan and colleagues point ... powering everything from smart phones to components in ...
Breaking Biology News(10 mins):Detecting mirror molecules 2Detecting mirror molecules 3Fish oil may help the heart beat mental stress 2
... into an aggressive sexual frenzy. Researchers writing in the ... a urine-mediated combination of aggressive and reproductive behaviour ensures ... Fiona Berry and Thomas Breithaupt from the University of ... on sexually active crayfish. Breithaupt said, "Our results confirm ...
... SEATTLE University of Washington (UW) researchers have gathered ... by overproducing protein-digesting enzymes. Plaques are fat-laden rough spots ... plaque ruptures, blood accumulates inside of it, a process ... clots can form. If the flow of oxygen-rich blood ...
... Five prominent physicists from leading U.S. and European universities will ... a daylong symposium presented by the Physics Department at The ... April 23, at The Harmonie Club in New York, will ... doctorate on Sy Sternberg, ,65 EE, former chairman and chief ...
Cached Biology News:Dangerous plaques in blood vessels rupture by overproducing protein-busting enzymes 2Dangerous plaques in blood vessels rupture by overproducing protein-busting enzymes 3Dangerous plaques in blood vessels rupture by overproducing protein-busting enzymes 4CCNY symposium April 23 to explore future of physics 2CCNY symposium April 23 to explore future of physics 3
Porcine Coronary Artery Smooth Muscle Cells (PCASMC) (>500,000 cells)...
... DNA Ligase catalyzes the joining of two ... the 3´-hydroxyl groups of adjacent nucleotides in ... The enzyme has also been shown to ... a DNA or RNA strand in a ...
... to MAP1 Light Chain MAP1A and MAP1B ... between microtubules and components of the cytoskeleton. MAP1A ... subunit and multiple light chain subunits. The protein ... light chain subunits and can associate with either ...
PC based system for advanced chemifluorescent, chemiluminescent, fluorescent and colorimetric, microarray and microscope imaging and analysis....
Biology Products: